Breaking News Instant updates and real-time market news.

CRM

Salesforce

$154.57

1.595 (1.04%)

, AKAM

Akamai

$74.91

0.5 (0.67%)

12:12
08/29/18
08/29
12:12
08/29/18
12:12

Fly Intel: What to watch in Salesforce earnings report

Salesforce (CRM) is scheduled to report results of its second fiscal quarter after the market close on Wednesday, August 29, with a conference call scheduled for 5:00 pm ET. What to watch for: 1. GUIDANCE: Along with its first quarter earnings in May, Salesforce raised its fiscal year 2019 revenue view to $13.075B-$13.125B from $12.66B-$12.71B and its FY19 adjusted EPS view to $2.29-$2.31 from $2.25-$2.27. Consensus, which stood at $12.75B and $2.13 for revenue and earnings at that time, has edged up to $13.13B and $2.32, respectively. 2. PARTNERSHIPS: In May, Akamai (AKAM) announced the release of the Akamai Connector for Salesforce Commerce Cloud. The integration of the Akamai Connector with Salesforce Commerce Cloud allows organizations to take advantage of Akamai's web performance solutions. Salesforce customers can leverage the Akamai Connector to achieve end-to-end performance and reliability, with the added benefit of the security protections inherent in Akamai's globally distributed cloud delivery platform. 3. ACQUISITIONS: In May, Salesforce announced that it had completed its acquisition of MuleSoft after announcing in March a definitive agreement under which it would acquire the company for an enterprise value of approximately $6.5B. Salesforce said, "With MuleSoft, Salesforce will accelerate customers' digital transformations, enabling them to unlock data across legacy systems, cloud apps and devices to make smarter, faster decisions and create highly differentiated, connected experiences for their customers." In July, Salesforce announced it had signed a definitive agreement to acquire Datorama, which chief analytics officer Bob Stutz called "the leading cloud-based, AI-powered marketing intelligence and analytics platform for enterprises, agencies and publishers." In a blog post, he said, "Datorama enables more than 3,000 leading global agencies and brands...to optimize marketing campaigns, automate reporting and make data-driven decisions faster. Salesforce's acquisition of Datorama will enhance the power of Marketing Cloud with expanded data integration and intelligence, enabling marketers to unlock insights across all of their marketing channels and data sources. With one unified view of data and insights, companies can make smarter decisions across the entire customer journey and optimize engagement at scale," Stutz said. 4. CO-CEO APPOINTMENT: In August, Salesforce announced that the company's board promoted Keith Block to co-CEO. Block, who remains a member of the board, most recently served as the company's chief operating officer since February 2016. In their respective roles as co-CEOs, Marc Benioff, who continues as chairman of the board, leads Salesforce's vision and innovation in areas including technology, marketing, stakeholder engagement and culture and Block leads the company's growth strategy, execution and operations.

CRM

Salesforce

$154.57

1.595 (1.04%)

AKAM

Akamai

$74.91

0.5 (0.67%)

  • 29

    Aug

  • 04

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 24

    Sep

  • 25

    Sep

CRM Salesforce
$154.57

1.595 (1.04%)

08/21/18
COWN
08/21/18
NO CHANGE
Target $165
COWN
Outperform
Salesforce price target raised to $165 from $155 at Cowen
Cowen analyst J. Derrick Wood raised his price target on Salesforce to $165 from $155 ahead of Q2 results. The analyst said channel checks indicate a solid beat and raise set-up, citing a re-acceleration in Sales and Service Cloud, growing Einstein adoption, and lower competition. Wood reiterated his Outperform rating on Salesforce shares.
08/22/18
JEFF
08/22/18
NO CHANGE
Target $168
JEFF
Buy
Salesforce price target raised to $168 from $155 at Jefferies
Jefferies analyst John DiFucci raised his price target for Salesforce to $168 ahead of the company's Q2 results. The analyst expects Salesforce meet or exceed consensus Q2 billings growth of 22%. Enterprise checks reflect strong results, particularly in Europe and across verticals, and a "healthy" second half of 2018 pipeline, DiFucci tells investors in a pre-earnings research note. The analyst keeps a Buy rating on the shares.
08/22/18
WEDB
08/22/18
NO CHANGE
Target $160
WEDB
Outperform
Salesforce price target raised to $160 from $150 at Wedbush
Wedbush analyst Steve Koenig raised his price target for Salesforce to $160 from $150 as his checks point to a strong demand environment and sustained momentum for Salesforce. While the analyst does not have evidence to suggest a repeat of the Q1 large deal performance, his checks anecdotally point to large deals closed in major verticals, and more in the pipeline. Koenig expects Salesforce's Q2 numbers will be strong, although the run-up in the shares year to date and over the last 90 days may create a more difficult setup. The analyst reiterates an Outperform rating on the shares.
08/22/18
RBCM
08/22/18
NO CHANGE
Target $155
RBCM
Outperform
Salesforce price target raised to $155 from $146 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Salesforce to $155 and kept his Outperform rating, saying his checks suggest continued "strong demand, success in multi-cloud deals at enterprise customers and pricing power". The analyst notes that the set-up on the stock is also "attractive" considering the implied organic constant-currency billings growth of around 15%. MacMillan adds that Salesforce has a historical pattern of beating Q2 consensus by about 5%, though this year's results may be skewed by the adoption of ASC606 standard.
AKAM Akamai
$74.91

0.5 (0.67%)

08/01/18
MKMP
08/01/18
NO CHANGE
Target $91
MKMP
Buy
Akamai pullback a buying opportunity, says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $91 price target on Akamai after its Q2 results, saying the pullback in the stock price from lower Q3 outlook may be a buying opportunity. Sanderson notes that the company's investment story remains intact with a lengthy opportunity for continued growth, also pointing to its operating expense efficiency, traction of new products, positive traffic trends, and stock buyback program.
08/13/18
FBCO
08/13/18
DOWNGRADE
FBCO
Neutral
Akamai downgraded to Neutral from Outperform at Credit Suisse
08/13/18
FBCO
08/13/18
DOWNGRADE
Target $84
FBCO
Neutral
Credit Suisse downgrades Akamai to Neutral after 29% rally
Credit Suisse analyst Brad Zelnick downgraded Akamai Technologies to Neutral from Outperform and lowered his price target for the shares to $84 from $88. The shares closed Friday down $2.18 to $74.66. With the stock up 29% since Elliott Management's disclosure of a stake on December 15, 2017, many of the catalysts have played out, Zelnick tells investors in a research note. The analyst views the stock's risk/reward as "increasingly balanced" at current levels. Further, he thinks "forthcoming headwinds may overshadow longer-term upside potential and challenge investors' confidence near term." Zelnick sees near-term headwinds coming from difficult comparisons in 2019 and continued momentum among asset-light competitors like Fastly and Cloudflare.
08/13/18
08/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rite Aid (RAD) downgraded to Market Perform from Outperform at Cowen with analyst Charles Rhyee saying shares of Ride Aid adequately reflect its outlook, following the termination of the company's merger with Albertsons. 2. Akamai (AKAM) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick saying with the stock up 29% since Elliott Management's disclosure of a stake on December 15, 2017, many of the catalysts have played out. 3. Alnylam (ALNY) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Terence Flynn saying the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. 4. Goodyear Tire (GT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Armintas Sinkevicius saying he remains "constructive" on the long-term growth for global miles traveled, but believes this will not affect the stock for the next 12 months due to the overhang from estimate achievability. 5. Dish (DISH) downgraded to Sell from Neutral at MoffettNathanson with analyst Craig Moffett saying while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NAV

Navistar

$23.84

-1.93 (-7.49%)

06:37
12/18/18
12/18
06:37
12/18/18
06:37
Earnings
Navistar sees FY19 revenue $10.75B-$11.25B, consensus $10.57B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

GD

General Dynamics

$163.43

-5.47 (-3.24%)

06:36
12/18/18
12/18
06:36
12/18/18
06:36
Periodicals
General Dynamics warns Canada over scrapping Saudi deal, Reuters reports »

General Dynamics Canadian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DPW

DPW Holdings

$0.14

-0.0138 (-9.21%)

06:34
12/18/18
12/18
06:34
12/18/18
06:34
Hot Stocks
DPW Holdings authorizes pursuit of IPO for DPW Technology Group »

DPW Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$23.84

-1.93 (-7.49%)

06:34
12/18/18
12/18
06:34
12/18/18
06:34
Earnings
Navistar reports Q4 EPS $1.89, consensus $1.71 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CNCE

Concert Pharmaceuticals

$13.69

0.16 (1.18%)

, ACRS

Aclaris Therapeutics

$6.99

-0.31 (-4.25%)

06:33
12/18/18
12/18
06:33
12/18/18
06:33
Recommendations
Concert Pharmaceuticals, Aclaris Therapeutics analyst commentary  »

Concert remains…

CNCE

Concert Pharmaceuticals

$13.69

0.16 (1.18%)

ACRS

Aclaris Therapeutics

$6.99

-0.31 (-4.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPK

Chesapeake Utilities

$87.88

-5.12 (-5.51%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Chesapeake Utilities subsidiary acquires propane operating assets in PA »

Chesapeake Utilities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSI

Smith Micro

$1.97

-0.11 (-5.29%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Smith Micro to acquire ISM Connect Smart Retail suite for $9.8M »

Smith Micro Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$5.94

0.08 (1.37%)

, GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Epizyme earns $8M milestone payment from GlaxoSmithKline »

Epizyme (EPZM) announced…

EPZM

Epizyme

$5.94

0.08 (1.37%)

GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

06:29
12/18/18
12/18
06:29
12/18/18
06:29
Downgrade
Flowserve rating change  »

Flowserve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$128.13

-2.89 (-2.21%)

06:29
12/18/18
12/18
06:29
12/18/18
06:29
Downgrade
Illinois Tool Works rating change  »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBB

Hubbell

$102.51

-0.405 (-0.39%)

06:28
12/18/18
12/18
06:28
12/18/18
06:28
Downgrade
Hubbell rating change  »

Hubbell downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:27
12/18/18
12/18
06:27
12/18/18
06:27
Periodicals
Nissan CEO to meet with Renault boss in Amsterdam, Reuters reports »

Nissan (NSANY) CEO Hiroto…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

MMTOF

Mitsubishi Motors

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

HST

Host Hotels

$17.31

-0.46 (-2.59%)

06:21
12/18/18
12/18
06:21
12/18/18
06:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSA

Public Storage

$199.42

-4.07 (-2.00%)

06:20
12/18/18
12/18
06:20
12/18/18
06:20
Upgrade
Public Storage rating change  »

Public Storage upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBE

CubeSmart

$30.16

-1.22 (-3.89%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
CubeSmart rating change  »

CubeSmart downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$20.75

-0.62 (-2.90%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
Invitation Homes rating change  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LSI

Life Storage

$98.10

-3.19 (-3.15%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
Life Storage rating change  »

Life Storage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$15.06

-0.53 (-3.40%)

, LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

06:16
12/18/18
12/18
06:16
12/18/18
06:16
Upgrade
Lionsgate, Use LGF.A, LGF.B, Lionsgate rating change  »

Lionsgate upgraded to Buy…

LGF.A

Lionsgate

$15.06

-0.53 (-3.40%)

LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

LGF.B

Lionsgate

$14.01

-0.48 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Hot Stocks
Elanco CEO says 'well positioned to grow top line revenue' »

"Our financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CS

Credit Suisse

$10.94

-0.155 (-1.40%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Periodicals
Credit Suisse advises clients to mull shifting assets out of UK, FT reports »

Private bankers at Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Earnings
Elanco sees FY19 adjusted EPS $1.02-$1.12 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ORCL

Oracle

$45.72

-0.9 (-1.93%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Recommendations
Oracle analyst commentary  »

Oracle posted 'solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$22.62

-0.17 (-0.75%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Hot Stocks
Radware announces deal with financial information technology provider »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATGE

Adtalem Global Education

$50.01

-1.14 (-2.23%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$279.17

-8.54 (-2.97%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Periodicals
Japan to purchase 100 additional F-35 stealth fighters, FT reports »

Japan has said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.